DR. DANIEL GARY KRAUSER M.D. NPI 1740338912

NPI Information

  • NPI: 1740338912
  • Provider Name: DR. DANIEL GARY KRAUSER, M.D.
  • Classification: Internal Medicine - 207RC0000X
  • Specialization: Cardiovascular Disease
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 133 E 58TH ST STE 301
    NEW YORK, NY
    ZIP 10022
  • Phone: (212) 755-8700

Map and Directions

Get Directions

NPI Details

DR. Daniel Gary Krauser, M.D. is a cardiovascular disease internal medicine in New York, NY with 25 years of experience. The provider is an internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms. DR. Daniel Gary Krauser, M.D. NPI is 1740338912. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2001

The provider's business location address is:

133 E 58TH ST STE 301
NEW YORK, NY
ZIP 10022-168
Phone: (212) 755-8700
Fax: (212) 755-5342

The NPI 1740338912 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
  • Injection, regadenoson, 0.1 mg (HCPCS:J2785)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Technetium tc-99m sestamibi, diagnostic, per study dose (HCPCS:A9500)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Ultrasound of heart with color-depicted blood flow, rate and valve function (HCPCS:93325)
  • Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report (HCPCS:93351)
  • Ultrasound of heart blood flow, valves and chambers (HCPCS:93320)
  • Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days (HCPCS:93296)
  • Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician (HCPCS:93015)
  • Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days (HCPCS:93294)
  • Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
  • Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec (HCPCS:G2066)
  • Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days (HCPCS:93297)
  • Heart rhythm review and interpretation of continous external ekg over 8-15 days (HCPCS:93248)
  • Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Programming of dual lead pacemaker system (HCPCS:93280)
  • Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Nuclear medicine study, 1 area with spect (HCPCS:78803)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries (HCPCS:A9538)

The enumeration date for this NPI number is 1/6/2007 and was last updated on 4/28/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RC0000XInternal MedicineCardiovascular Disease231653NEW YORKYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.